TNF and inflammatory bowel disease: Monoclonal antibody-mediated blockage of the proinflammatory cytokine tumour necrosis factor alpha (TNF α) is effective at reducing IBD in many cases, highlighting the key role TNF α plays in intestinal inflammation2.